0001140361-20-009478.txt : 20200422 0001140361-20-009478.hdr.sgml : 20200422 20200422191423 ACCESSION NUMBER: 0001140361-20-009478 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200420 FILED AS OF DATE: 20200422 DATE AS OF CHANGE: 20200422 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bjork Elisabeth CENTRAL INDEX KEY: 0001810406 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36829 FILM NUMBER: 20808886 MAIL ADDRESS: STREET 1: C/O ROCKET PHARMACEUTICALS, INC. STREET 2: 350 FIFTH AVENUE, SUITE 7530 CITY: NEW YORK STATE: NY ZIP: 10116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ROCKET PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001281895 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 350 FIFTH AVENUE STREET 2: SUITE 7530 CITY: NEW YORK STATE: NY ZIP: 10118 BUSINESS PHONE: 646-440-9100 MAIL ADDRESS: STREET 1: 350 FIFTH AVENUE STREET 2: SUITE 7530 CITY: NEW YORK STATE: NY ZIP: 10118 FORMER COMPANY: FORMER CONFORMED NAME: INOTEK PHARMACEUTICALS CORP DATE OF NAME CHANGE: 20040226 4 1 form4.xml FORM 4 X0306 4 2020-04-20 0001281895 ROCKET PHARMACEUTICALS, INC. RCKT 0001810406 Bjork Elisabeth C/O ROCKET PHARMACEUTICALS, INC. 350 FIFTH AVENUE, SUITE 7530 NEW YORK NY 10118 true Stock Option (Right to Buy) 17.5 2020-04-20 4 A 0 40000 0 A 2030-04-20 Common Stock 40000 40000 D This option represents a right to purchase a total of 40,000 shares of the Issuer's Common Stock, 1/3 of which shall vest on the first anniversary of the date of this grant and the remaining 2/3 of which shall vest in equal monthly installments over the subsequent two years. /s/ Sara Turken, as attorney-in-fact 2020-04-22